MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

Day One Biopharmaceuticals Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

6.39 -1.84

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

6.31

Max

6.59

Pagrindiniai rodikliai

By Trading Economics

Pajamos

30M

-36M

Pardavimai

1.6M

31M

Pelno marža

-117.018

Darbuotojai

181

EBITDA

24M

-40M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+313.54% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-07-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-101M

702M

Ankstesnė atidarymo kaina

8.23

Ankstesnė uždarymo kaina

6.39

Naujienos nuotaikos

By Acuity

50%

50%

169 / 376 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Day One Biopharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-17 23:34; UTC

Įsigijimai, susijungimai, perėmimai

FTC Reopens Consent Orders for Proposed Acquisitions from Exxon Mobil, Chevron

2025-07-17 21:14; UTC

Įsigijimai, susijungimai, perėmimai

Basel Medical Group Puts $1 Billion Bitcoin Purchase on Hold

2025-07-17 21:04; UTC

Pagrindinės rinkos jėgos
Įsigijimai, susijungimai, perėmimai

Norfolk Southern Shares Rise on WSJ Report of Union Pacific Acquisition Interest

2025-07-17 23:43; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Position Adjustments -- Market Talk

2025-07-17 23:42; UTC

Rinkos pokalbiai

Nikkei May Rise on Signs of U.S. Econ Strength -- Market Talk

2025-07-17 22:47; UTC

Įsigijimai, susijungimai, perėmimai

FTC: Maintaining Restrictions for Former Pioneer CEO Scott Sheffield Would Damage FTC's Credibility

2025-07-17 22:46; UTC

Įsigijimai, susijungimai, perėmimai

Potential Rail Merger Could Prompt Berkshire Hathaway to Bid for CSX -- Barrons.com

2025-07-17 22:46; UTC

Įsigijimai, susijungimai, perėmimai

FTC Also Says Exxon Order Disregarded Guidelines and Precedent

2025-07-17 22:43; UTC

Įsigijimai, susijungimai, perėmimai

FTC: Maintaining Restrictions on John Hess's Employment Would 'Damage the FTC's Credibility'

2025-07-17 22:43; UTC

Įsigijimai, susijungimai, perėmimai

FTC: Chevron Order Disregarded FTC Merger Guidelines and Decades of Precedent

2025-07-17 22:40; UTC

Įsigijimai, susijungimai, perėmimai

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

2025-07-17 22:40; UTC

Įsigijimai, susijungimai, perėmimai

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

2025-07-17 22:30; UTC

Rinkos pokalbiai
Uždarbis

Netflix Sticks to Its Playbook as Competitive Landscape Changes -- Market Talk

2025-07-17 22:20; UTC

Rinkos pokalbiai
Uždarbis

Global Equities Roundup: Market Talk

2025-07-17 22:20; UTC

Rinkos pokalbiai
Uždarbis

Netflix Focusing Resources on TV Viewers It Hasn't Yet Captured -- Market Talk

2025-07-17 22:04; UTC

Rinkos pokalbiai
Uždarbis

Netflix Redesign Done to Match Current Capabilities -- Market Talk

2025-07-17 22:03; UTC

Įsigijimai, susijungimai, perėmimai

China Threatens to Block Panama Ports Deal Unless Its Shipping Giant Is Part of It -- 2nd Update

2025-07-17 21:58; UTC

Rinkos pokalbiai
Uždarbis

Netflix Internal Data Doesn't Indicate Weaker Consumer Sentiment -- Market Talk

2025-07-17 21:57; UTC

Uždarbis

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

2025-07-17 21:47; UTC

Uždarbis

Netflix Raises Revenue, Margin Forecasts After Strong Second Quarter -- Update

2025-07-17 21:45; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-17 21:45; UTC

Rinkos pokalbiai

Crypto Bills Welcomed by Venture Capital, Trade Group Says -- Market Talk

2025-07-17 21:38; UTC

Įsigijimai, susijungimai, perėmimai

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- 2nd Update

2025-07-17 21:22; UTC

Įsigijimai, susijungimai, perėmimai

Update: Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

2025-07-17 21:05; UTC

Uždarbis

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

2025-07-17 21:04; UTC

Įsigijimai, susijungimai, perėmimai

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- Update

2025-07-17 21:02; UTC

Įsigijimai, susijungimai, perėmimai

Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

2025-07-17 20:59; UTC

Įsigijimai, susijungimai, perėmimai

Basel Medical Group Puts $1B Bitcoin Purchase on Hold

2025-07-17 20:50; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-07-17 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Day One Biopharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

313.54% į viršų

12 mėnesių prognozė

Vidutinis 26.88 USD  313.54%

Aukščiausias 36 USD

Žemiausias 18 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Day One Biopharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

9 ratings

8

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

6.26 / 7.47Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

169 / 376 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.